AI Audit Trail Review Checklist
Overview
This AI Audit Trail Review Checklist provides a structured, ready-to-use framework for reviewing audit trail records generated by AI-enabled GMP systems. It helps organizations assess whether audit data is complete, trustworthy, and compliant with ALCOA+, 21 CFR Part 11, and broader pharmaceutical data integrity expectations.
Who Is This For?
- QA professionals
- Data Integrity Officers
- Compliance teams
- IT validation engineers
- Regulatory auditors
Use Cases
- Periodic audit trail reviews for AI systems
- Data integrity assessments
- Regulatory inspection preparation
- Internal audits of AI-enabled LIMS/ERP/MES
- ALCOA+ compliance verification
Download
The template is available in both editable Word format and PDF for printing or reference.
Key Benefits
- Systematic approach: Provides a repeatable method for evaluating audit trail controls across AI-enabled GMP systems
- Regulation-aligned: Aligned with 21 CFR Part 11 and EU GMP Annex 11 expectations for secure, reviewable records
- ALCOA+ focused: Covers ALCOA+ principles comprehensively to support trustworthy electronic records
- Audit-ready: Supports documented evidence that can be retained for inspections and internal reviews
- Adaptable: Can be applied to different AI system types including LIMS, ERP, MES, and supporting quality platforms
What the Template Covers
- AI system audit trail completeness checks
- User action traceability verification
- Data modification tracking assessment
- Electronic signature compliance
- Metadata integrity validation
- Anomaly detection in audit records
Related Articles
- AI and Audit Trail Review: Data Integrity
- AI and Data Integrity: Enforcing ALCOA+ in Pharmaceutical Systems
- 21 CFR Part 11 and AI in Pharmaceutical Systems
- Validating AI Systems in Pharma
- Preparing for FDA Inspections: AI Systems
Disclaimer
This template is provided for educational and informational purposes only. It does not constitute regulatory advice, legal guidance, or a validated quality system document. Organizations should adapt this template to their specific regulatory requirements, quality management systems, and internal SOPs. Always consult with qualified regulatory and quality professionals before making compliance decisions.